Small Towns, Big Pharma

January 18, 2017

We’ve written before about skyrocketing drug prices.  These prices can disproportionately affect middle-class and working-class folks at the pharmacy counter. (You know, average Americans like you and us). 

But even without nonsensical increases, prescription drug costs are still high, which is part of the broader trend of rising health care costs – particularly high premiums. So, how much is the Rx price tab for average Americans? Roughly $1,370 annually. It’s a problem either way. If you’re insured you end up paying higher premiums, but if you’re not, you end up paying the amount in full. That’s one heavy burden – especially if you need specialty medication.

For instance, Pfizer has been criticized in the news for acquiring Medivation, which makes the prostate cancer drug Xtandi. Xtandi costs roughly four times as much in the United States as it does in most other countries and can be up to a whopping $129,000 for a course of treatment. We understand people’s frustration, but as it turns out, North Carolina also needs Pfizer to succeed. (Conundrum, much?)

Pfizer, the nation’s largest drug company, has a solid presence here. One of their global plants is located in Rocky Mount (at least for the moment), where it employs around 2,000 people—just shy of 8% of the city’s total workforce. That’s hefty, for a single company. And in Sanford, Pfizer (operating as Wyeth Pharmaceuticals, which they acquired in 2009) is the largest employer in town. Which means that, at least for a lot of folks down East, Pfizer’s fate is our fate too.

So, it’s a complicated issue right? North Carolinians need lower drug costs, but we also need Pfizer to succeed. One solution that can make us all feel better; drug pricing transparency.

Some drug companies (Johnson & Johnson, for instance) are now making an effort to be more transparent in their drug pricing. If they’re going to raise prices, they’re letting you know up front how much — and in some cases, why.

North Carolina should be encouraging as much voluntary transparency into drug pricing as possible, not just because it benefits our citizens, but because it may benefit our economy.

So, recap: down with soaring drug prices. Up with voluntary transparency. And let’s encourage good decisions on the part of one of North Carolina’s staple industries — for everyone’s benefit.

We’re here to champion the right to more affordable health insurance by decreasing state government mandates. Want to know more? Join us.

!
Action Needed

Tell your representative to say "no" to higher drug costs

We’ve told you about big Pharma’s brazen attempt to gut the last remaining protection for patients against runaway drug prices.

Now the most profitable industry in the world is quietly pushing a bill through the state legislature that would cripple pharmacy benefit managers (PBMs), which negotiate lower drug costs for North Carolinians.

We cannot let big pharma use the law to eliminate our only advocate in price negotiations.


Comment on This Article   

Post Your Comment

Please check your e-mail for a link to activate your account.

Related Articles

Rep. Pittman and the NFIB – Standing up for lower health care costs
Insys Therapeutics Admits to Bribing Doctors to Write Opioid Prescriptions
Federal Judge’s Ruling Deals Blow to Quest for Drug Price Transparency

Featured Articles

Surprise Billing: Arbitration Will Raise Your Premiums
SB 432 – Lots of Treats for Pharmacists – and Bad News for Consumers
Why do Pharmaceutical Companies hate PBMs so much?
Creators of Mysterious Ad Blitz Influencing Anti-Surprise Billing Law Comes to Light
Benchmarking, Not Arbitration, is the Answer to America’s Surprise Billing Problem
Podcast: Senator Joyce Krawiec Talks to Us About Why CON Laws are Bad for NC